[{"Assets_0_Q2_USD":"4393384000.0","CIK":"1048477","CommonStockSharesConverted_0_Q2_shares":"179433316.0","CommonStockSharesOutstanding_0_Q2_shares":"179433316.0","Country":"United States","EarningsPerShareBasic_1_Q2_USD":"-0.21","EarningsPerShareBasic_2_Q2_USD":"-0.53","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"14899091235.0","NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":"-79206000.0","NetIncomeLoss_1_Q2_USD":"-37435000.0","NetIncomeLoss_2_Q2_USD":"-93908000.0","OfficialName":"BioMarin Pharmaceutical Inc. Common Stock","RevenuesConverted_1_Q2_USD":"387763000.0","RevenuesConverted_2_Q2_USD":"788508000.0","SP500":null,"Sector":"Health Care","StockholdersEquity_0_Q2_USD":"2960954000.0","Ticker":"BMRN","WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":"179048000.0","WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":"178662000.0","filed":"20190802","footnote":null,"form":"10-Q","fp":"Q2","fy":"2019.0","name":"BIOMARIN PHARMACEUTICAL INC","period":"20190630","qtrs":"0","uom":"USD"}]